Rifampicin Production Cost Analysis 2019

Rifampicin (also known as Rifampin) belongs to the class of antimycobacterial and is mainly used in pharmaceutical industry as an antibiotic to treat bacterial infections, including tuberculosis, leprosy, and legionella.

Procurement Resource provides an in-depth cost analysis of Rifampicin production. The report incorporates the manufacturing process with detailed process and material flow, capital investment, operating costs along with financial expenses and depreciation charges. The study is based on the latest prices and other economic data available. We also offer additional analysis of the report with detailed breakdown of all cost components (Capital Investment Details, Production Cost Details, Economics for another Plant Location, Dynamic Cost Model).

Reports

Rifampicin Production from Mixed Carbon Source
  • Rifampicin Production from Mixed Carbon Source

    This report presents the economics of rifampicin production from mixed carbon sources (peanut meal, soybean flour, glucose, and starch) via a typical fermentation process.

    Analysis Basis: Germany

    Period of Analysis: Q3 2019

    Starting at USD 1199


Supply Demand and Market Analysis


Feasibility Studies


Techno-economic Evaluations


Investment Analysis


Multi-regional Cost Analyses

Evaluate Other Plant Locations

This report presents an analysis of capital and operating costs of a -based industrial plant. For those interested in economic assessments considering other plant locations, Procurement Resource offers optional analyses that complement this report.